B Group acquired 90,000 shares of Structure Therapeutics in the fourth quarter. The quarter-end position value increased by $6.26 million due to the new holding. The new stake accounted for 4.62% of ...

Astronomers have produced the most detailed map yet of dark matter, revealing the invisible framework that shaped the Universe long before stars and galaxies formed. Using powerful new observations ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. After the ...

If you had sharp eyes on Sunday night while watching the 2026 Golden Globes, you would've noticed that there was a hot new accessory on the red carpet. Mark Ruffalo, Wanda Sykes, Natasha Lyonne, Jean ...

But what if the biggest giveaway that a text was written by AI isn’t a word, phrase, or punctuation mark, but a particular sentence structure instead? The idea that certain rhythms of sentences might ...

Anchor your business to a stubborn, real-world problem customers cannot ignore. Replace hustle with systems that standardize decisions, data flow and accountability. Ambition isn’t what holds ...

Structure’s aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech’s stock up nearly 103% as markets closed on Monday. Structure Therapeutics’ investigational oral GLP-1 ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Structure Therapeutics ...

Cybersecurity researchers are calling attention to a new campaign dubbed JS#SMUGGLER that has been observed leveraging compromised websites as a distribution vector for a remote access trojan named ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...